Proteomics International Laboratories’ PromarkerD blood test has proven to be a step up in predicting chronic kidney disease in a WA-based study of diabetes patients. Proteomics International Laboratories’ PromarkerD blood test has proven to be a step up in predicting chronic kidney disease in a WA-based study of diabetes patients. Business / Companies Sydney Morning Herald – Latest News
Perth trial proves worth of Proteomics diabetes-related blood test
